Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In
  • Become a Member
  • MB Vision
  • Members
    • Become a Member
      • Types & Rates
    • Benefits
      • Savings and Rewards
    • Member News
    • Member Events
    • Career Center
    • Directory
    • Pay Company Dues
    • FAQs
  • Events
    • Upcoming
    • Types of Events
    • Sponsorship Opportunities
    • The State of Possible Conference
    • Align Summit
    • Member Events
  • Innovation
    • About
    • Drive
      • Application
      • Alumni
      • Partners – MassBio
      • Partners – SCbio
      • Get Involved
      • FAQs
    • CEO & Founder Link
    • Align Summit
    • Partnering
    • Sponsorship Opportunities
  • Savings
    • MassBioEdge
  • Conference Center
    • About MassBioHub
    • Packages & Special Offers
    • Venue Specifications
    • Reserve Today
  • Policy & Advocacy
    • Policy & Advocacy Efforts
    • Diversity, Equity, and Inclusion
      • DEI Report
      • Resource Center
      • Open Letter 2.0
      • Bioversity
    • Economic Development
      • BioReady® Communities
    • Workforce Development
      • Bioversity
    • Vision 2030
    • This is the place.
    • Industry Reports
      • Federal Actions Impact Report
      • Industry Snapshot
      • Biopharma Funding Report
      • DEI Report
      • MA Life Sciences Workforce
  • About
    • About MassBio
    • News & Thought Leadership
    • MB Vision
    • The Studio at Kendall Square
    • Sponsorship Opportunities
    • Staff
    • Board
    • Contact Us
  • Sign In
  • Become a Member
  • MB Vision
Open search form

Member Directory

Click to Open Main Menu

Rentschler Biopharma Inc

Life Sciences | Contract Research & Manufacturing
Milford, MA 5082825800 Website LinkedIn

Overview

Rentschler Biopharma – Your trusted CDMO partner from concept to market

 

Rentschler Biopharma is a leading global contract development and manufacturing organization (CDMO) offering process development and cGMP manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies. Rentschler Biopharma is a family-owned company headquartered in Laupheim, Germany, with a second site, Rentschler Biopharma Inc. in Milford, MA, USA. A third site in Stevenage, UK, is dedicated to cell and gene therapies. In 2023, Rentschler Biopharma contributed to four of the seventeen, which equals nearly 25%, new biopharmaceuticals approved by the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) (Rentschler Biopharma Contributes to Nearly 25% of FDA Approved Biopharmaceuticals) (Rentschler Biopharma Contributes To Nearly 25% of FDA-Approved Biopharmaceuticals). The company is committed to advancing medicine to save lives and helps provide essential therapies for millions of patients with serious and rare diseases.

 

In recent years, Rentschler Biopharma Inc. in Milford, MA, has grown from a single-product commercial facility to a multi-product facility. A new state-of-the-art manufacturing facility at the existing site, the Rentschler Biopharma Manufacturing Center (RBMC), adds 22,000 square feet of manufacturing cleanroom space and houses four new 2,000 L single-use bioreactors. This is the largest expansion in the company’s more than 150-year history and will double Rentschler Biopharma’s global cGMP capacity. The facility will primarily focus on the commercial production of highly complex molecules for international clients and will be operational this year. In December 2023, the Company announced that it had secured a major client for the RBMC for an innovative protein therapeutic for a form of cancer (Rentschler Biopharma Announces Major Client Project for New US Facility at Milford). By contributing to the global availability of biopharmaceuticals, Rentschler Biopharma, Milford recently won the Gold MassEcon Impact Award (Rentschler Biopharma Takes Home the Gold MassEcon Impact Award), for its strong commitment to diversity as well as its community presence, including its partnerships with local schools and organizations.

Website: http://www.rentschler-biopharma.com    LinkedIn: https://www.linkedin.com/company/rentschler-biopharma-se 

Company News

News

Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development

Feb 20, 2025

Posted by Rentschler Biopharma Inc

Whitepapers

RENTSCHLER BIOPHARMA LAUNCHES NEW WHITE PAPER: Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation

Nov 19, 2024

Posted by Rentschler Biopharma Inc

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • News & Thought Leadership
  • Pay Company Dues
  • Join Today
  • Contact
  • Privacy Policy
  • © 2025 All Rights Reserved